Oscar Health, Inc.

NYSE:OSCR

Medical - Healthcare Plans

Healthcare
$27.57 +0.18%

+$0.05 today

Market cap
$7.15B
Beta
2.39
P/E (TTM)
-214.2
EPS (TTM)
-$0.13
52W Low $10.69High $29.81

Volume 7.38M

Average 7.51M

OSCR EBITDA Margin

EBITDA as a percentage of revenue.

Oscar Health, Inc.NYSE: OSCR

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 8.1%

EBITDA Margin was 8.1% in Q2 FY2026, up 15.8 pp from a year earlier. On a trailing-twelve-month basis it was 4.1%, up 5.0 pp year over year. Over 3 fiscal years it widened by 10.5 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 6 analysts of 4.6% for the fiscal year ending Dec 2026, up from -3.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
8.1%-7.2 pp QoQ
Last fiscal yearDec 2025
-3.3%-4.3 pp YoY
LTMJun 2026
4.1%+5.0 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+15.8 pp+3.4 pp-12.4 pp
1 year-4.3 pp+7.9 pp+12.2 pp
3 years+10.5 pp+7.8 pp-2.7 pp
5 years+8.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-3.3%
Year-over-year change
-4.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How OSCR compares with its peers on the latest reported figures

  • OSCR's LTM Jun 2026 EBITDA Margin of 4.1% is the 3rd highest of the 8 companies compared; the peer median is 1.6%.
  • Its year-over-year change of +5.0 pp is the highest of 8, against a peer median of -0.4 pp.
  • Over three fiscal years its change of +10.5 pp compares with a peer median of -1.6 pp.
OSCR Competitors Peer median
EBITDA Margin for OSCR and competitors
Company Period LTM level YoY 3-year change
ELVElevance Health Inc.LTM Sep 20264.4% -0.7 pp-1.6 pp
CICigna CorporationLTM Sep 20264.4% -0.2 pp-2.1 pp
OSCROscar Health, Inc.LTM Jun 20264.1% +5.0 pp+10.5 pp
CVSCVS Health CorporationLTM Jun 20263.2% -0.4 pp-1.4 pp
ALHCAlignment Healthcare, Inc.LTM Mar 20261.6% +2.9 pp+9.1 pp
MOHMolina Healthcare, Inc.LTM Sep 20260.8% -2.7 pp-2.1 pp
CLOVClover Health Investments, Corp.LTM Jun 2026-0.7% +1.9 pp+18.6 pp
CNCCentene CorporationLTM Jun 2026-1.4% -4.0 pp-5.5 pp
Peer median (excluding OSCR) 1.6%-0.4 pp-1.6 pp

Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.92B4.13B5.86B9.18B11.7B
Cost of Revenue004.64B7.33B10.02B
Gross Profit1.92B4.13B1.22B1.84B1.68B
Gross Margin100.0%100.0%20.8%20.1%14.4%
Research & Development00000
Selling, General & Admin265.08M1.42B002.05B
Operating Expenses2.49B4.74B1.46B1.79B2.08B
Depreciation & Amortization14.61M15.28M30.69M32.15M28.89M
EBITDA(551.26M)(572.17M)(212M)89.31M(391.05M)
EBITDA Margin-28.7%-13.9%-3.6%1.0%-3.3%
Operating Income(570.58M)(610.08M)(235.62M)57.27M(396.36M)
Operating Margin-29.7%-14.8%-4.0%0.6%-3.4%
Interest Income00000
Interest Expense4.72M22.62M24.6M23.73M17.6M
Other Income / Expenses00(31.69M)(23.84M)(40.94M)
Income Before Tax(570.58M)(610.08M)(267.3M)33.43M(437.3M)
Pre-Tax Margin-29.7%-14.8%-4.6%0.4%-3.7%
Income Tax Expense846K(523K)3.29M7.31M5.61M
Net Income(572.61M)(606.28M)(270.73M)25.43M(443.15M)
Net Margin-29.8%-14.7%-4.6%0.3%-3.8%
EPS (Basic)(3.19)(2.85)(1.22)0.11(1.69)
EPS (Diluted)(3.19)(2.85)(1.22)0.10(1.69)
Weighted Avg Shares178.97M212.47M221.66M240.39M262.39M
Weighted Avg Shares (Diluted)178.97M212.47M221.66M265.85M262.39M

Oscar Health, Inc.

NYSE:OSCR

Intrinsic Alpha fair value

Locked

Current Price

$27.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.